Planning Strategies’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Planning Strategies's UTHR Position: Q3 2026 in Review
Planning Strategies held its United Therapeutics (UTHR) position steady in Q3 2026 at 1 share worth $542. The position accounts for ﹤0.01% of the portfolio, ranked #914.
Planning Strategies first reported a position in UTHR in Q2 2026 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Planning Strategies held 1 share of United Therapeutics worth $542 as of Q3 2026.
- Planning Strategies left its United Therapeutics share count unchanged in Q3 2026.
- United Therapeutics made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #914 holding.
- Planning Strategies first reported a position in United Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.